Spectroscopic metabolic abnormalities in mTLE with and without MRI evidence for mesial temporal sclerosis using

Susanne G Mueller1, Kenneth D Laxer, Joyce Suhy

  • 1Department of Veterans Affairs (DVA) Medical Center, Magnetic Resonance Spectroscopy Unit Pacific Epilepsy Program, California Pacific Medical Center, San Francisco, California 94115, U.S.A.

Epilepsia
|June 26, 2003
PubMed
Abstract

Insights

Short echo time magnetic resonance spectroscopic imaging (MRSI) accurately lateralizes the seizure focus in mesial temporal lobe epilepsy (mTLE). Myoinositol (MI) may aid focus identification, though further research is needed.

Area of Science:

  • Neuroimaging
  • Epilepsy Research
  • Metabolic Spectroscopy

Background:

  • Mesial temporal lobe epilepsy (mTLE) diagnosis often relies on identifying the epileptogenic hippocampus.
  • Long echo time (TE) magnetic resonance spectroscopic imaging (MRSI) is established for this, but short-TE MRSI offers additional metabolic insights.
  • Short-TE MRSI may be susceptible to artifacts, necessitating careful evaluation.

Purpose of the Study:

  • To assess the capability of short-TE MRSI for lateralizing the seizure focus in mTLE.
  • To determine the utility of myoinositol (MI) levels in identifying the epileptogenic hippocampus.

Main Methods:

  • Hippocampal 2D short-TE MRSI was performed on 24 patients with temporal lobe epilepsy (TLE) and 16 controls.
  • Patient groups included 16 with TLE and mesial temporal sclerosis (TLE-MTS) and 8 with normal MRI (TLE-No).

Main Results:

  • In TLE-MTS, ipsilateral N-acetylaspartate (NAA) was significantly decreased compared to controls or the contralateral side (p ≤ 0.03).
  • Ipsilateral myoinositol (MI) was also decreased in TLE-MTS patients compared to controls (p = 0.012).
  • Short-TE MRSI accurately lateralized the epileptogenic hippocampus in up to 82% of TLE-MTS and 80% of TLE-No patients.

Conclusions:

  • Short-TE MRSI at 1.5 T demonstrates comparable accuracy to long-TE MRSI for seizure focus lateralization in mTLE.
  • Myoinositol (MI) shows potential as a biomarker for focus lateralization, but influencing factors require further investigation.